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With the observations of immune complexes or antigens in the circulation of patients 
with rheumatoid arthritis (1, 2), systemic lupus erythematosus (3, 4), and other dis- 
eases, much attention has been drawn to their possible significance in the pathogenesis 
of the lesions  in these disorders.  Abundant data derived from experimental models 
have shown that the presence of complexes in the circulation coincides temporally with 
the development of the lesions, e.g., acute glomerulonephritis and vasculitis (5, 6) and 
chronic glomerulonephritis (7). In these studies the complexes were demonstrable in 
the lesions, and it was reasonably presumed that they reached their destination in the 
tissues after passage through the circulation. 
Previous studies in this series have analyzed the mechanisms by which circulating 
immune complexes  are capable of localizing in vessel walls.  It was found that com- 
plexes localized in blood vessd walls only during an increase in vascular permeability 
and that the complexes were trapped along the vascular basement membranes during 
the passage of plasma fluids  through the permeable membrane (8). The increase  of 
vascular permeability was brought about in particular by vasoactive amines and hista- 
mine that were released from their tissue reservoirs, the mast cells, by the action of the 
complexes  themselves (9).  The accompanying article presents data  suggesting  that 
this mechanism of localization  is instrumental in serum sickness. 
The present paper deals with  the physicochemical properties of complexes 
and with the concentration of complexes in the plasma required for detectable 
localization  to occur. The validity of these findings  is  tested  in  experimental 
serum sickness of rabbits, a disease known to be caused by deposition of circu- 
lating immune complexes. A preliminary report has been presented (10). 
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Materials and Methods 
Animals.--Male albino guinea pigs obtained from a  closed colony and weighing 250-300 
g each were used throughout. New Zealand rabbits weighing 2.5 kg were used in the prepa- 
ration of antisera. 
Antigens.--Rabbit  gamma globulin (RGG), fraction H, was obtained from Pentex, Inc., 
Kankakee,  Ill. Human gamma globulin (HGG), fraction II, was kindly donated  by Dr. J. 
H. Pert of the American Red Cross,  through the courtesy of E. R. Squibb and  Sons  (New 
York, N. Y.).  Five times crystallized bovine serum albumin  (BSA)  was obtained from the 
Armour Pharmaceutical Company, Kankakee, Ill. Horse spleen ferritin, cadmium free, and 
human  fibrinogen were obtained from Nutritional Biochemical Company,  Cleveland, Ohio. 
Highly purified bovine thyroglobulin and  keyhole limpet hemocyanin  (KI,H)  were kindly 
donated  by  Dr.  R.  Nakamura  and  Dr.  W.  O.  Weigle.  Associated KLH was prepared  by 
bringing the pH to 6.6 and dissociated  by dialyzing associated KLH against barbital buffer, 
pH 8.6 overnight. The dissociated KLH was then centrifuged at 35,000 rpm for 90 rain and 
the protein in  the top  three-quarters  of the tube removed by aspiration.  Verification that 
the KLH was in the associated or dissociated  form was obtained by sucrose density gradient 
ultracentrifugation. 
Antibodies.--Anti-BSA,  anti-RGG,  and  anti-guinea  pig  complement,  i.e.  antibody  to 
the third component of guinea pig complement, were obtained as noted previously (8). Anti° 
body to ferritin, human fibrinogen,  KLH, and human ~'M-globulin were obtained by injecting 
rabbits with 5-15 mg of each antigen contained in incomplete Freund's adjuvant. Two weekly 
injections of the above doses were given and the animals were bled after 2 wk. Highly purified 
human q,M-giobulin was obtained from the serum of a  patient with Waldeustrom's macro- 
giobulinemia, kindly donated by Dr. H. Fudenberg. The ~/M-globulin was purified by euglobu- 
lin precipitation followed  by Pevikon block electrophoresis,  passage through DEAE-cellulose 
(diethylaminoethylceUulose)  with elution produced by a sodium chloride gradient  of 0-0.3 ~s 
followed by passage through a Sephadex G-200 column. The final product gave a single band 
when tested with anti-whole human serum in agar diffusion  plates. Antibody concentrations 
of each antiserum were obtained by the quantitative precipitin test (11). 
Radioisotope Labeling of Proteins with i~lI.---~81Idabeling  of anti-BSA was carried out by 
the method described in this laboratory (12). 
Preparation of Soluble Antigen-Antibody  Complexes.--Soluble  antigen-antibody  complexes 
were prepared by first precipitating the antibody from an antiserum at the point of equiva- 
lence. The precipitates were washed three times in 0.15 ~r NaC1 at 4°C and then dissolved in 
an excess of antigen. The amount of antigen generally used for solubilization was equal to 20 
times that required for precipitation at equivalence (20 X  equivalence). Since the precipitates 
were thoroughly washed, the only globulin present in the soluble complex preparation repre- 
sonted  antibody  globulin.  As noted  before  (8),  the preparation  and  in  vivo localization of 
complexes was not affected by prior decomplementation of the immune serum. 
Method for  Obtaining  Localization of  Circulating Antigen-Antibody  Complexes.--Soluble 
immune complexes were injected intravenously into guinea pigs in  the doses noted  below. 
These doses  were insufficient,  in themselves, to cause anaphylaxis  and  increase in vascular 
permeability. Thus, either immediately or at the times noted in the results, 200 #g of histamine 
(Base) were then given intravenously in order to increase artificially the permeability of blood 
vessels throughout  the guinea pigs.  During the increase in permeability of the blood vessels, 
the circulating immune complexes became entrapped in the vessel walls (8, 9). Mter  1 or 2 
rain, i.e. the time required for death to occur as a result of histamine injection, the lungs were 
removed and decompressed,  and sections were obtained for analysis by fluorescent antibody 
techniques. While death generally resulted from the injection of histamine, it did not appar- 
ently  influence  the  quantity  of  deposition  of  complexes.  Guinea  pigs  having  severe but C.  O.  COCHRANE  AND  D.  HAWKINS  139 
nonfatal anaphylaxls or those saved from a  fatal outcome immediately prior to death by an 
intravenous  injection of  antihistamine  showed  an  amount  of  complex deposition  in  blood 
vessel Walls indistinguishable from that  in guinea pigs dying from the exogenously admin- 
istered  histamine.  The  lungs  were  used  for reproducibility  and  convenience, other  organs 
showing vessels with similar complex deposition. 
Fluorescent Antibody  Tedm/quz.--The technique used was that of Coons and Kapian  (13) 
with the  addition  of minor modifications.  Controls employed in  these fluorescent antibody 
studies were the same as those listed previously (8). 
Complemenl Depletion of Guinea Pigs.--Depletion of circulating  complement was obtained 
by injections of heat-aggregated human gamma globulin as described previously (8). 
He~olyt~c  Compl~  L~ds.--Hemolytic  complement  levels  were  measured  by  the 
C~I-Ii0 analysis (15). This was modified for determinations in rabbits (16). 
Ultracentrifugation 
Sucrose Density Grodi~  Ultrac~ifuga~.--Sucrose  gradients  of 10-37% were prepared 
on a  Buckler gradient preparation  device. Linearity of the gradients  of sucrose was verified 
by carbohydrate analysis of 20 sequential eluates in each of the three tubes.  In experiments, 
0.1-0.3 ml of sample was applied to the top of each tube.  In comparative experiments, the 
identical volume was added  to each centrifuge tube.  Centrifugation was then carried out in 
a  Spinco Model L  ultracentrifuge,  employing a  T-50 swinging  bucket rotor,  at 50,000  rpm 
for a period of 4 hr. A hole was then made in the bottom with a needle and the drops exiting 
from the tubes were counted. Protein analysis of the resulting fractions was obtained by the 
Folin technique. 
Analytical  Ultrcwentrifugc~ion.--Analytical ultracentrifugation was carried out in a  Model 
E  Spinco ultracentrifuge at 20°C and 57,564 rpm. 
Electrophore.sis: Paper electrophoresis was performed on a  Spinco dectrophoresis apparatus 
using 0.01 ~  phosphate  buffer,  pH  7.0 for a  period of  16 hr.  Analysis of the stained paper 
strips was performed  using a  Spinco Analytrol.  Preparatory  electrophoresis was performed 
employing Pevikon as supporting medium. Electrophoresis was carried out for 20 hr at 4°C 
and 400 v using 0.01 ~r phosphate buffer pH 7.0. Agar electrophoresis  employing 0.7% ionagar 
with 0.01 M phosphate pH 7.2 was used. E1ectrophoresis  was carried out on  microscope slides 
for 2  hr  at  200  v  or approximately  10  v  per  centimeter.  Microimmunoelectrophoresis was 
performed according  to  the microadaptation  (17) of  the immunoelectrophoretic method  of 
Williams and Grabar  (18). The conditions of electrophoresls were the same as those described 
under electrophoresis in agar above. 
Serum  sickness: Rabbits  weighing 2.5  kg  were given 250  mg  BSA/kg labeled  with  zszI 
(I* BSA). In half the rabbits,  measures were taken to increase the animals' responses  to the 
I* BSA and thereby increase the frequency and severity of lesions. These consisted of inject- 
ing 5 nag N  anti-BSA/kg 20 hr before the I* BSA and 10 pg Escherickia col,  i endotoxin with 
the I* BSA as described previously (16).  Serum was obtained  by centrlfugation at  20-30°C 
in order to minimize changes in the binding ratios of the antigen-antibody complexes when 
formed, lSZI activity of the serum was measured in a  scintillation counter and  tests for the 
amount  of I*  BSA bound  to globulin were performed  by  precipitating  the giobulins  with 
ammonium sulfate at  4°C at a  final concentration of one-half saturation  of ammonium sul- 
fate. The precipitates were washed twice and counted. 
All rabbits in the serum sickness  groups were sacrificed  when more than 99% I* BSA was 
eliminated from the circulation. Tissues were placed in  10%  formalin for histologie studies 
and frozen for fluorescent antibody analysis. Proteinuria was measured  by the sulfosalicylic 
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RESULTS 
The  Concentration of Immune  Complexes in  the  Circulation Required for 
Detectable Localization in Blood Vessel Walls.-- 
Soluble  BSA-anti-BSA complexes  were prepared in vitro in antigen excess 
using an amount of antigen equal to 20 times that at equivalence (20 X  equiva- 
lence). Varying amounts were injected intravenously into guinea pigs followed 
immediately by histamine, intravenously, to permit localization  of the circu- 
lating complexes (Fig. 1). The small doses of complexes did not induce anaphy- 
laxis or increase vascular premeability by themselves; and deposition of com- 
plexes was never seen in the absence of anaphylactic signs  (regularly induced 
by histamine). It was found that injected doses of complexes of 50 ~g Ab ~ or 
greater were sufficient  to yield consistent, strong localization  in 250-g guinea 
TABLE I 
Quantity  of Circulating  Soluble Complexes Required/or Detectable Localization* 
No. guinea pigs  Complexes circulating  Detectable localization 
Itg Ab N/ml plasma 
5-10 
11-15 
15--20 
20-30 
+ 
+ 
* Soluble complexes prepared at 30  X  equivalence. Localization attempted within 1 rain 
after injection. 
pigs, while injections of 20 #g Ab 1~ produced minimal visual localization.  The 
concentration of complexes in the circulation required for visual localization  by 
fluorescence was determined by employing 1311 anti-BSA in preparations of the 
complexes.  The results, shown in Table I, indicate that visual localization in 
vessel walls occurred if plasma levels were 15 Izg Ab N or greater per ml. 
Relationship  of Molecular Weight  and  Electrostatic Charge to  the Ability of 
Circulating Molecules to Become Localized in Blood Vessel Walls.-- 
Molecular weight: Several different protein molecules  of varying molecular 
weights were injected intravenously into guinea pigs in order to find if a rela- 
tionship existed between this property and the ability to become localized along 
basement membrane in vessel walls.  In Table H  it is shown that molecules 
ranging  in weight from 68,000 (bovine albumin) to 800,000 (dissociated hemo- 
cyanin) or 900,000 (human 3,M-globulin) failed to localize. However, molecules 
of greater  weight,  such  as  associated hemocyanin  at  7,500,000,  or  immune 
complexes  made at 20  ×  equivalence did deposit.  Sucrose gradient ultracen- 
trifugation revealed that  the associated and dissociated hemocyanin samples 
were not contaminated each by the other.  In addition,  guinea pig ~/-globulin C.  G.  COCHRANE AND D.  HAWKINS  141 
was not deposited with the hemocyanin, suggesting that these animals did not 
have a natural antibody directed against this protein. 
In order to examine in greater detail the physical properties of the BSA-anti- 
BSA complexes made at 20  X  equivalence that would localize and those at 
100  X  equivalence that would not localize (Table II), sucrose gradient (10- 
37 %) ultracentrifugafion of each type complex was performed. In Text-fig. 1, 
it  may be seen that both families of complexes displayed a  large peak that 
sedimented relatively slowly. However, complexes made at 20 X  equivalence 
had a more rapidly sedimenting component as seen in tubes two to eight. A 
TABLE II 
Rdationship  of Molecular Size and Electrostatic Charge and the Ability  to Localize in Vessd 
Walls during Increased Permeability 
No. of  guinea  Te~t material*  Approximate  Appro:dmate  Electrophoretic  Local- 
plgs  mol wt  sedimentation rate  mobldity$  izatiOnvesselsin 
8 
7 
6 
4 
6 
10 
15 
BSA 
HGG 
Bovine thyroglobulin 
Hemocyanin (dissociated) 
TM-globulin 
BSA-anti-BSA  complexes, 
100 X equivalence 
BSA-anti-BSA  complexes, 
20 X equivalence 
HGG-anti-HGG  complexes, 
20 X equivalence 
Heat-aggregated HGG 
Hemocyanin (associated) 
68,000 
160,000 
670,000 
814,000 
900,000 
7,500,000 
4S 
7S 
19S 
18S 
19S 
9S 
9 to >  30S 
9 to >  30S 
>  30S 
98S 
albumin 
'y-globulin 
a-globulin 
B-globulin 
fl-globulin 
/3-globulin 
/~-globulin 
3,-globuiin 
m 
a-globulin 
+ 
+ 
+ 
+ 
* Amounts employed varied between 0.5 and 10.0 mg protein. 
Position of each test material in electrophoresis  designated by comparison with zones 
of normal serum tested simultaneously. 
similar difference between complexes prepared at 20 and 100  X  equivalence 
was  found  in  analytical  ultracentrifugafion  (Text-fig.  2).  Analytical  ultra- 
centrifugation was carried out to avoid separation of large complexes from the 
surrounding milieu of antigen as occurs in density gradient ultracentrifugafion. 
Of note, an initial advancing shoulder was seen at 24 rain in the pattern of 
complexes made at 20 X  equivalence. This was followed by a distinct, rapidly 
sedimenting peak noted at 40 min. This peak did not consist of a stable complex, 
however, since a straight line plot did not exist when log x was plotted against 
time of centrifugafion. As in density gradient ultracentrifugation, the complexes 
made at 100 X  equivalence failed to demonstrate a rapidly sedimenting com- 
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In order to test the significance of these two sedimentation patterns, several 
pools were made from the collected tubes after density gradient ultracentrifuga- 
tion employing complexes made at 20  and  100  X  equivalence. Human "),M- 
globulin protein was centrifuged simultaneously as  a  sedimentation marker. 
The pooled samples were immediately injected intravenously into guinea pigs 
followed by histamine to permit localization of  the complexes.  The results, 
shown in Text-fig.  1,  indicated that complexes having a  sedimentation rate 
greater than 19S readily localized, while those less than 19S would not. Corn- 
tr  1-2+  3+  3+  tr  0  20x Equiv. 
I  II  II  '  I:  ;:  ~1  '  I 
i..__O_..4~___O._4n__O_,~.O.__,._..O__.~.O_..i  lOOx Equiv. 
Localization in Vessel Wails 
"~  1,'  tSs  ~4~,- ",, 
"~'M"  G  I u  b  u  l'?"//  '"~",, 
:  ° 20, Equ,v.  /./  \i 
._  .....  ,ooxT/ 
Ultracentrifuge Tube Number 
ITExT-FIo. 1.  Patterns  of sedimentation  of I*  anti-BSA complexes with BSA using two 
quantities of BSA. Sedimentation carried out in a  linear sucrose  gradient,  10-37%,  4 hr at 
50,000 rpm. Purified human "vM served as marker. Those made using a  large excess of BSA 
(100 X  equivalence) yielded slowly sedimenting complexes,  while those prepared in moderate 
antigen excess  (20 X  equivalence) demonstrated both slowly sedimenting and more rapidly 
sedimenting  components.  Fractions  collected after  centrifugation  and  injected  into  guinea 
pigs showed localizing complexes only in tubes taken from complexes prepared at 20 X  equiv- 
alence and greater than 19S in size. 
plexes made at 100  X  equivalence failed, as before, to become localized even 
though considerable amounts sedimented in the 19S region of the centrifuge 
tube. Of special note, the results demonstrated that the complexes prepared at 
20 X  equivalence contained both localizing and nonlocalizing complexes.  The 
great majority of these, between 87 and 71%, was not able to localize in vessel 
walls. 
Electrostatic charge: The charge of various molecules tested in the preceding 
section was  determined  electrophoretically employing Pevikon block,  paper 
strip, or agar gel as supporting media. This was carried out at pH 7.0; i.e., at a 
pH close to that of plasma. The experimental data shown in Table II indicate 
that molecules migrating in gamma, beta, and alpha zones were able to localize C.  G.  COCHRANE AND  D.  tIAWKINS  143 
in  blood vessel walls;  e.g.,  HGG-anti-HGG complexes, BSA-anti-BSA  com- 
plexes, and associated hemocyanin, respectively. And as a corollary, molecules 
migrating in these same electrophoretic positions, e.g.  HGG (nonaggregated), 
"yM-globulin, and  thyroglobulin or ferritin, failed to become deposited along 
vascular basement  membrane during  the state  of increased permeability.  In 
addition,  the more negatively charged bovine albumin  also  failed to deposit. 
Thus, a correlation was not found to exist between electrophoretic mobility of 
the molecules and their ability to localize in blood vessel walls. 
TEXT-FIG.  2.  Analytical  ultracentrifugation  patterns  of  the  same  two  soluble  BSA- 
anti-BSA complexes shown in Text-fig.  1.  Upper frame, complexes prepared at  I00  X  equiv- 
alence.  Lower  frame,  complexes  prepared  at  20  X  equivalence.  Frames,  reading from left 
to  right,  taken  at  16,  32,  and  40 min  after centrifuge reached  two-thirds maximum speed. 
A rapidly sedimenting boundary is apparent in the complexes prepared at 20 X  equivalence. 
Possible Affinity of Soluble Immune Complexes for Vascular  Basement  Mem- 
brane.- 
In  order to find if circulating immune complexes would become deposited 
along vascular basement membranes or endothelial cells by virtue of an affinity 
of the complexes for these structures, soluble complexes in large amounts (1.0 
mg Ab N at 20 X  equivalence) were injected intravenously into six guinea pigs. 
Histamine was not administered.  No signs of anaphylaxis were noted and the 
animals were sacrificed after 3 to 5 min.  A careful search was made of vessels 
in the lungs, heart, liver, and kidneys, including the glomerulus, for deposition. 
In none of the vessels  were complexes found localized. 144  CIRCULATING IMMUNE COMPLEXES 
The El~ect of Time in the Circulation  on the  Types of Complexes  Remaining 
and on Their Ability to Become  Localized.- 
In  preliminary studies  it  was  observed  that  when  histamine  was  injected 
later than 2 rain after infusion of the complexes to permit localization, little or 
no vascular deposition was obtained. In order to gain greater understanding of 
this  observation, soluble  BSA 131I-anti-BSA  complexes prepared  at 30  times 
equivalence were prepared and injected intravenously into guinea pigs.  His- 
tamine was administered at various times thereafter to evoke increased perme- 
ability of vessels.  As noted in Text-fig. 3, complexes injected over a wide dosage 
range failed to become localized when they were allowed to circulate more than 
2 min before histamine was given. 
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TExT-Fro.  3.  Relationship of  the ability of  soluble  complexes  to  localize  in  guinea  pig 
vessels to the amount injected and the time after injection that localization  was attempted. 
BSA-anti-BSA complexes prepared at 30 X  equivalence. 
Analyses were made of the complexes remaining in  the circulation after 2 
rain that were nonlocalizing. Plasma was obtained from guinea pigs at various 
times after injection of the complexes to compare their pattern of sedimentation 
in sucrose gradient with their ability to localize. Typical patterns are given in 
Text-fig. 4  for complexes in plasma  obtained 0.33,  0.85,  and  13.0  min  after 
injection. While a prominent peak of rapidly sedimenting complexes was found 
in the early bleedings, only a small amount of these complexes was present after 
13 min in the circulation. Although not shown in Text-fig. 4, samples taken 27 
min after injection showed no heavy component. Animals given histamine at 
the shorter time intervals gave definite vascular localization of the complexes, 
whereas those similarly examined at 13 min did not. C.  G.  COCHRANE  AND  D.  HAWKINS  145 
The  Effect  of  Complement  (C')  on  the  Ability  of  Circulating  Complexes  to 
Become Localized.- 
Without doubt, the components of plasma C' rapidly bind to immune com- 
plexes as they circulate.  This has been observed both by an  immediate fall in 
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TExT-FIG. 4. Sucrose density ultracentrifugation of serum obtained from  a  guinea pig 
0.33, 0.85, and I3.0 rain after injection of BSA-anti-BSA complexes  prepared at 20 X  equiv- 
alence. 
TABLE III 
Effect of Complement Binding on th* Ability of Circulating Complexes to Localize in Vessels* 
C'-depleted 
Normal 
Complex type:~ 
20 
75 
20 
75 
No. of.guinea 
ptgs  C'Hso (average) 
115 
115 
Localization in vessels 
RGG  C' 
I-2+  0-4- 
1+  0-4- 
1-3+  1-2+ 
1+  1+ 
* Guinea pigs injected with BSA-anti-BSA complexes (made from C'-depleted antiserum) 
using 300/zg Ab N. Guinea pigs depleted of C' with heat-aggregated HGG. 
20, 20 X  equivalence; 75, 75 X  equivalence. 
hemolytic C' levels after injection of soluble complexes and by visualization of 
Ct3  on complexes phagocytized by leukocytes within 30  sec of injection.  To 
test  the  possible  influence  that  C'  binding  might  have  upon  the  ability  of 
circulating complexes to localize, guinea pigs were depleted of C ~ by injections 
of  heat-aggregated  HGG.  A  second  group  with  normal  C'  levels  served  as 
normal control.  Immune complexes made at 20  X  equivalence, in doses near 146  CIRCULATING  IMMUNE  COMPLEXES 
the threshold  of visualization  were then  injected intravenously followed im- 
mediately by histamine.  As noted in Table III,  despite the depletion of C', 
localization  of  the  immune  complexes  was  apparent  in  quantities  indistin- 
guishable from those of normal animals.  From previous studies (19) it is known 
that  treatment  with  heat-aggregated  HGG  removes  all  measurable  C'1,4 
activity and hence the binding of all C' components is prevented. The absence 
of guinea pig C' binding in C'-depleted guinea pigs was confirmed by fluorescent 
antibody techniques. 
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TExT-FIo. ,5. Relationship of the sedimentation rate of soluble  complexes and their ability 
to induce increased vascular permeability in guinea pig skin. 
Tests were also carried out as above, but employing soluble complexes pre- 
pared at 75  X  equivalence to find if these smaller complexes  would localize 
more readily if their overall size were increased by bound C' components. Doses 
were employed to give threshold localization  in the vessel walls. Despite the 
absence of hemolytic C r, no differences in localization  were observed in the two 
groups (Table III). 
Cutaneous  Reactivity  of Soluble  Complexes  both Capable  and  Incapable  of 
Localizing  in Blood  Vessel  Walls.- 
Tests were performed on the ability of the heavier (localizing)  and lighter 
(nonlocalizing)  sedimenting components of complexes prepared at 20 X  equiv- 
alence to cause increased vascular permeability in  guinea  pig  skin.  Accord- 
ingly, complexes  obtained from ultracentrifuge  tubes corresponding to tubes 
2 through  7 and  9 through  12 of Text-Fig.  1  were  diluted  in  saline  to  in- 
sure isotonicity, and injected intradermally into  the skin of guinea  pigs that 
had  previously  received  Evan's  blue  intravenously.  The  result,  shown  in 
Text-fig. 5, reveal that  both rapidly and  slowly sedimenting  complexes  had Rda~io~hip  oJ the  Sedimentation 
Dcvdc 
Rabbit No.* 
Group 
I*BSA bound to 
globulin  at 
maximums 
% 
I" 
50-91  26 
50-97  40 
51-01  43 
53-35  45 
53-37  49 
53-38  42 
53-41  56 
53-44  29 
53-45  61 
TABLE IV 
?haractcristics  of  Circulaling  Immune  Complexes  to  the 
~ment of Lesions  in Serum Sick~ss 
Pattern of 
I*BSA 
sc~llmentation§ 
H 
H 
H 
H 
H 
H 
H 
H 
H 
Glomernlar 
lesionsll 
2+ 
3+ 
2+ 
2+ 
2+ 
3+ 
3+ 
I+ 
3+ 
Protelnuria 
(rag total) 
159 
1750 
815 
980 
465 
258 
130 
0 
50 
Maximum C' 
depletion 
80 
79 
81 
81 
73 
82 
73 
70 
84 
Average.  43.3  H  2.3+  567  78 
L 
L 
L 
L 
L 
40 
37 
22 
60 
29 
0 
-4- 
-t- 
O 
0 
Group II: 
50-93 
50-95 
50-99 
51-00 
53-42 
80 
66 
42 
86 
62 
Average...  41.6  L  0-:k  0  67 
Group III: 
50-92 
50-96 
50-98 
51-02 
53-36 
53-39 
53-43 
0 
9 
7 
9 
12 
9 
9 
10 
Average.  A 
--¶ 
* All rabbits with numbers beg~nniug with 50 or 51 were given I* BSA 250 mg/kg to in 
duce  serum  sickness.  Rabbits  with  beg~nnlng numbers  53  were  injected  with  anti-BSA 
(5 nag Ab N/kg) 20 hr before the I ~ BSA and 10 ~g E. coli endotoxin with the I* BSA. 
Per cent I* BSA bound to globulins determined by precipitation of the globulins with 
ammonium sulfate at 50% saturation. 
*§ H, heavy; L, light; A, albumin. Pattern of sedimentation of I* BSA in density gradient 
ultracentr~ugation revealing I*  activity below the tenth fraction tube from  the meniscus 
(15 drops/tube) is described as '~heavy"; sera showing no I* activity below the eleventh frac- 
tion tube from the meniscus of the ultracentrifuge tube are designated "light." Alb., sedi- 
mentation pattern of albumin in normal serum. See Text-fig. 7. 
I] Glomerular lesions were graded 0-3+,  depending on the degree of endothelial swelling 
and proliferation. 
¶  Values were all within normal range. 148  CIRCULATING  IMMUNE  COMPLEXES 
the capacity to increase vascular permeability, although the slowly sediment- 
ing complexes were less active in this regard. All reactions reached a maximum 
in 20-30 rain. 
The Presence of Rapidly Sedimenting Complexes in the Circulation during the 
Development of Serum Sickness Lesions.- 
Attempts were made to find if a correlation existed between the presence of 
large, rapidly sedimenfing complexes in the circulation and the development of 
acute vascular and glomerular lesions in serum sickness.  I*BSA was iniected 
100 
10  ~~,,\\, 
\ 
1  51-01 .... (815 mE Proteinuria)  ~, 
51-00__  (Omg Proteinuria)  \X  x 
,I  , 
.  ![   lli' 
!l 
100 ..{ 
80  -= 
6o  ~ 
4D  ~ 
20  .~ 
14  2  4  6  8  1O  12 
Days 
TExT-FIG. 6. Rate  of elimination of I*  BSA from the circulation of two rabbits, No. 
51-00 and No. 51-01, and the amount of I* BSA bound to globulin as determined by precipi- 
tation in ammonium sulfate at 50% saturation. 
into 22 rabbits to induce serum sickness,  and on various days the sera were 
tested for the presence of immune complexes and subjected to ultracentrifuga- 
fion in density gradient. On the basis of the sedimentation of I*BSA, rabbits 
were divided into three groups: (a) those with "heavy" or rapidly sedimenting 
complexes; (b)  those with  "light"  or slowly sedimenting  complexes; and  (c) 
those not making a detectable immune response. Sera with "heavy" complexes 
were those in which the I*BSA sedimented more than 11 fraction tubes from 
the meniscus (e.g. tube 17 in Text-fig. 7), while the I*BSA in those with "light" 
complexes sedimented less than 11 fraction tubes from the meniscus was at tube 
27. Maximal sedimentation rates were generally observed on day 10 or 11, those 
tested on day 7 or 8 being lighter. 
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group I developed severe lesions in arteries and glomeruli and had considerable 
proteinuria. An example of a typical severe glomerular lesion is shown in Fig. 2. 
By contrast, rabbits in group II having "light" complexes developed few or no 
lesions of serum sickness, even though there were considerable amounts of com- 
plexes circulating for 2  or more days.  Fig.  3  shows a  glomerulus from a  rep- 
resentative rabbit of group II  (No.  51-00) that had  more  than 40%  I*BSA 
bound to globulin, but whose complexes were "light" at all times. In Text-fig. 
6, elimination of I*BSA in this rabbit is compared with that of another rabbit, 
No. 51-01, that developed "heavy" complexes and severe arteritic and glomeru- 
lar lesions.  One notes that despite the presence of complexes for many days in 
the circulation, the rate of elimination of I*BSA after day 8 is slightly slower 
in No. 51-00 than in rabbit 51-01. The sedimentation patterns of rabbits hay- 
600 
---53-41 Day 9 
500  --51-00 DaylO 
400  ---51-02 Day 10  ~'M-Giobuliq  ,/'  "~  /  \ 
,L  i  i/"~  ;  p  30{  v  i  I/  ~k  , 
-  /  ~  ~' 
10~  _._/  ........  . 
i  i  i  .  i  i  i  i  i  i  i  ,  i  • 
2  4  6  8  10  12  14  16  18  20  22  24  26  28 
Tube Number 
TExT-FIG.  7.  Sedimentation patterns of I* BSA in sera obtained from three rabbits at 
the times shown after injection of I* BSA. Centrifugation carried out in linear sucrose density 
gradient 10-37%  at 50,000 rpm for 4  hr. No. 51-00 demonstrates a  typical "light" pattern 
and No. 53-41 a  "heavy" pattern. No. 51-02 failed to develop antibodies and showed a sedi- 
mentation pattern of free BSA in normal serum. 
ing  "light"  (No.  51-00)  and  "heavy"  (No.  53-41) complexes  are  shown in 
Text-fig. 7, together with the sedimentation pattern of I*BSA in a  rabbit (No. 
51-02)  that did not make a detectable immune response and therefore showed a 
pattern of I*BSA in normal serum. 
Fluorescent antibody studies of the kidneys revealed in each case examined 
that the complexes were deposited in glomeruli of those rabbits with lesions 
(group I) but not in others (groups II and III). 
Examination of the heart  and coronary arteries  in rabbits  of each  group 
revealed marked endocarditis and a  high  incidence of vasculitis in rabbits of 
group I. An average of 3 zones  (range of 0-5) of arterial inflammation and 3.1 
zones (range 1-6)  of endocarditis were found per  rabbit. Only two rabbits in 
group II had endocardial inflammation and one (No. 50-95)  had a mild focus 
of arteritis. None of the animals in group III had vascular disease. 
As  a  measure of biologic activity of the circulating complexes, hemolytic 
(C'I-~0) assays were determined on each rabbit at intervals during the course of 150  CIRCULATING  ~UNE  COMPLEXES 
the experiments.  In all cases where  immune complexes were formed,  C'Hs0 
values dropped considerably  (Table  IV).  The amount was somewhat greater 
on the average  in group I  than group II rabbits,  but considerable  overlap 
occurred between values in the two groups. 
DISCUSSION 
Factors Governing tke  Ability  of Circulating  Soluble Complexes to  Become 
Localized in  Blood Vessel Walls.--The  experimental  results  presented  here 
suggest  that the most important factor governing whether or not circulating 
immune complexes will localize in blood  vessels is  the size of the complex 
molecules. This was demonstrated in several ways: 
1.  When small complexes were prepared in vitro by using a large excess of 
antigen, localization  in vessel walls failed  to occur.  When less  antigen was 
employed in the preparation, larger complexes formed, as was verified by both 
sucrose density gradient and analytical ultracentrifugafion (Text-figs. 1 and 2), 
and these large complexes were able to become entrapped in vessel wails. 
2.  Complexes prepared in a moderate excess of antigen (20  ×  the amount 
needed  at equivalence or 20  ×  equivalence)  that did deposit in vessels were 
found by analytical and density gradient ultrazentrifugation to consist  of a 
spectrum of molecular sizes. Of these,  only those complexes greater than 19S 
in size were found capable of being trapped in vessel wails. 
3.  Employing an unrelated protein, keyhole limpet hemocyanin (KLH), a 
similar relationship of the molecular size to the ability to localize in vessels was 
observed. Associated KLI-I with a molecular weight of 7,000,000 was capable of 
localizing. However, when dissociated into 18S subunlts of 800,000 molecular 
weight, the KLH no longer would deposit in vessel walls. 
Two other possible mechanisms of localizations were found not to be related 
to the ability of complexes to localize: 
1.  No relationship could be found between the ability of complexes to localize 
and their net charge. As shown in Table II, localizing molecules were found in 
the  gamma,  beta,  and  alpha  electrophoretic  regions  (e.g. HGG--anti-I-IGG 
complexes,  BSA-anti-BSA  complexes at  20  X  equivalence,  and  associated 
KLH) in paper,  agar, and Pevikou electrophoresis. By the same token, other 
molecules  having  similar  migrational characteristics  in  electrophoresis  (e.g. 
HGG, ~/M-globulin, dissociated KLH and BSA-anti-BSA  complexes prepared 
at 100 ×  equivalence, and thyroglobulin)  failed to localize. 
2. There was no apparent affinity between  circulating  immune complexes 
and  vascular  structures.  Complexes  were  never  observed  along  basement 
membranes in the absence of increased vascular permeability.  This was true 
even in renal glomeruli where the complexes in the plasma had intimate contact 
with the basement membrane.  It was also found to be the case in rabbits in 
which  complexes existed  in the circulation,  but in which their deposition  in C. G.  COCHRANE  AND  D. HAWKINS  151 
glomertfli and arteries could be prevented by inhibition of vasoactive amines 
(see reference  20). 
The Molecular Size Required for Localization to Occur in Vessel Walls.--The 
data  obtained from preparatory ultracentrifugation  revealed that  complexes 
greater in size than  19S were required for localization  in vessel walls to occur. 
The minimal size may well be larger than this. Soluble complexes prepared far 
in antigen excess (100 X  equivalence) did not localize despite the presence of 
some complexes having sedimentation rates of about 19S. In addition, proteins 
such  as  19S  human  ~,M-globulin,  dissociated  hemocyanin  (18S,  molecular 
weight  800,000)  and  thyroglobulin  failed  to  localize.  However,  circulating 
complexes smaller than  19S may reflect the presence of a pathogenic process; 
As demonstrated in these studies, the small complexes may represent the lower 
portion of a spectrum of sizes, the larger complexes being more rapidly removed 
from the circulation.  Within  13 man nearly all complexes greater than 22S in 
size were removed from the circulation of guinea pigs, while the plasma level of 
smaller complexes was not greatly changed. 
Correlation between the Size of Circulating Complexes in Serum Sickness,  Their 
Deposition in  Vessels, and  the Formation  of Lesions.--The data in Table IV 
demonstrated that the deposition of circulating complexes and the development 
of glomerular lesions in serum sickness of rabbits was found predominantly in 
animals forming large immune complexes (more than 19S in size). Proteinuria, 
glomerulitis,  endocarditis, and arteritis were found commonly in this group and 
to a far lesser degree in rabbits with more slowly sedimenting complexes.  The 
levels of complexes in the two groups of rabbits were approximately the same. 
While much larger complexes, such as those prepared in vitro were not detected 
in large amount in the rabbits with serum sickness,  the possibility exists that 
such complexes are formed in these rabbits, but are rapidly removed. Evidence 
indicating the rapid removal of large complexes was cited above. 
While the data presented suggest that the failure of lesions to develop may be 
explained by the inability of small complexes to become entrapped in arterial 
and  glomerular  basement membranes,  consideration  must  be  given  to  the 
possibility that the rabbits with lesions produced complexes that were patho- 
genic  for reasons unrelated  to  the  size.  Three  observations,  however, argue 
against  this.  Rabbits producing  both  "light"  and  "heavy"  complexes  were 
found to have marked depletion of hemolytic complement activity, suggesting 
that both types of complexes possessed pathogenic qualities. Two such qualities 
known  to  be  dependent  upon  complement  activation  by antibody  are  the 
formation of anaphylatoxin  (21-23) and the accumulation of leukocytes (24). 
The latter of these qualities is undoubtedly fundamental to the development of 
serum sickness lesions  (16, 20). Secondly, as noted in Text-fig.  5, even "light" 
complexes  are capable of inducing  considerable increase  in  vascular  perme- 
ability. And finally,  with the large amounts of complexes  formed in the rab- 152  CIRCULATING  TI~,TUNE  COMPLEXES 
bits--upward to 60 %  of the antigen being  bound by globulin--it is  highly 
unlikely  that  antibody  with  pathogenic  capacities  was  not  produced.  In 
addition, in experiments  of chronic  serum  sickness  (7),  the observation was 
made that rabbits given greater amounts of antigen than were needed to neu- 
tralize circulating antibody, failed to develop chronic nephritic lesions. It was 
postulated that complexes formed were too small. The present studies in acute 
serum sickness lend support to this postulation and suggest that the inability 
of complexes to localize and reach sufficient concentrations on the glomerular 
basement membrane may account for this finding. 
The  Influence  of  Complement on  the  Localization  of  Circulating  Immune 
Complexes.--In the present studies, no effect of complement  (C') was found on 
the ability of circulating complexes to localize in vessel walls. Even complexes 
just sufficient in size to deposit in vessel walls were not augmented in this regard 
by the presence  of C' in the circulation.  Apparently the smallest  complexes, 
such as those prepared at 100 X equivalence, that do not localize are not able 
to bind C' (25). Hence, they do not receive the additional increment of size 
offered to the complex when C' binds. In addition, the data suggest that once a 
complex is sufficiently large to fix C', it is large enough to become entrapped by 
the vascular basement membrane. It must also be noted that binding of C' 
components  does not apparently augment trapping of complexes by vascular 
basement membrane. 
SUMMARY 
The relationship  between certain physicochemical properties  of circulating 
immune complexes and their ability to localize in vessel walls during a state of 
increased  permeability was  studied.  The  ability to  become  deposited  was 
related to the large size of complexes, rather than to their net charge or to a 
specific affinity between complexes and structures of vessel walls. 
Soluble complexes with sedimentation rates greater than 19S were capable 
of being entrapped along the vessel wall membranes,  while complexes smaller 
than this were  not.  These large  complexes were  removed  rapidly from the 
circulation, while smaller complexes persisted. Minimal levels of total complexes 
in the circulation necessary for detectable vascular localization were found to be 
as low as 15 ~g antibody N/ml plasma. 
In experimental serum sickness, a disease known to be induced by circulating 
immune complexes, the development of vascular and glomerular  lesions oc- 
curred almost exclusively in rabbits having large (greater than 19S) circulating 
immune complexes. Animals with smaller complexes did not show deposition 
of complexes in glomeruli or development of glomerulonephritis. Their incidence 
of vasculitis was markedly reduced. 
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EXPLANATION OF PLATES 
P~  21 
Fro. 1.  Fluorescent photomicrograph  of a small vessel in the lung of a guinea pig 
showing the deposition  of BSA-anti-BSA complexes in the vessel wall. This section 
was treated with fluorescent anti-RGG. Treatment with fluorescent anti-BSA or anti- 
guines pig C'3 gave a similar fluorescent pattern. Electron photomicrographs in previ- 
ous  studies  showed the complexes and  other markers  to lie  between  and  beneath 
endothelial  ceils, up agMnst the limiting basement membranes.  X 350. TIlE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  127  PLATE 21 
(Cochrane and  Hawkins:  Circulating immune complexes) PLATE 22 
FI6.2.  Photomicrograph of a glomerulus taken from a rabbit (50-97)  with rapidly 
sedimenting complexes. Marked swelling of cells is observed, typical of the glomerulus 
of acute serum  sickness. BSA, RGG,  and  rabbit C'3 were all visualized in this glo- 
merulus by fluorescent techniques.  X  500. 
FI6.3.  Photomicrograph of a  glomerulus from a  rabbit (51-00)  with slowly sedi- 
menting complexes (See Text-figs. 6 and  7).  No observable alteration is present and 
immune complexes were not detected by fluorescent antibodies.  X  500. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 127  PLATE  22 
(Cochrane and  Hawkins:  Circulating immune complexes) 